Nevertheless, it is noteworthy that our conclusion based on the obtained results – with an established primarily heterozygous mutant IDH1 fibrosarcoma cell line – are in harmony with those reported by Carbonneau et al [44]. The gene discussed is IDH1; the disease is fibrosarcoma.